BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1348094)

  • 1. Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome?
    Stern HJ; Saal HM; Lee JS; Fain PR; Goldgar DE; Rosenbaum KN; Barker DF
    J Med Genet; 1992 Mar; 29(3):184-7. PubMed ID: 1348094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus.
    Sharland M; Taylor R; Patton MA; Jeffery S
    J Med Genet; 1992 Mar; 29(3):188-90. PubMed ID: 1348095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association.
    Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D
    Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
    Colley A; Donnai D; Evans DG
    Clin Genet; 1996 Feb; 49(2):59-64. PubMed ID: 8740913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus.
    Ahlbom BE; Dahl N; Zetterqvist P; Annerén G
    Clin Genet; 1995 Aug; 48(2):85-9. PubMed ID: 7586657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for linkage to the type 1 or type 2 neurofibromatosis loci in Noonan syndrome families.
    Flintoff WF; Bahuau M; Lyonnet S; Gilgenkrantz S; Lacombe D; Marçon F; Levilliers J; Kachaner J; Munnich A; Le Merrer M
    Am J Med Genet; 1993 Jul; 46(6):700-5. PubMed ID: 8362913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
    Stevenson DA; Viskochil DH; Rope AF; Carey JC
    Clin Genet; 2006 Mar; 69(3):246-53. PubMed ID: 16542390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan phenotype associated with neurofibromatosis.
    Allanson JE; Hall JG; Van Allen MI
    Am J Med Genet; 1985 Jul; 21(3):457-62. PubMed ID: 2411134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene.
    Dalili S; Hoseini Nouri SA; Bayat R; Koohmanaee S; Tabrizi M; Zarkesh M; Tarang A; Mahdieh N
    Hum Genomics; 2023 Feb; 17(1):12. PubMed ID: 36803953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping a gene for Noonan syndrome to the long arm of chromosome 12.
    Jamieson CR; van der Burgt I; Brady AF; van Reen M; Elsawi MM; Hol F; Jeffery S; Patton MA; Mariman E
    Nat Genet; 1994 Dec; 8(4):357-60. PubMed ID: 7894486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular studies in a large Dutch family with Noonan syndrome.
    van der Burgt I; Berends E; Lommen E; van Beersum S; Hamel B; Mariman E
    Am J Med Genet; 1994 Nov; 53(2):187-91. PubMed ID: 7856646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1.
    Upadhyaya M; Fryer A; MacMillan J; Broadhead W; Huson SM; Harper PS
    J Med Genet; 1992 Mar; 29(3):180-3. PubMed ID: 1348093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?
    Yapijakis C; Pachis N; Natsis S; Voumvourakis C
    In Vivo; 2016; 30(3):315-20. PubMed ID: 27107091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new nonsense mutation in the NF1 gene with neurofibromatosis-Noonan syndrome phenotype.
    Yimenicioğlu S; Yakut A; Karaer K; Zenker M; Ekici A; Carman KB
    Childs Nerv Syst; 2012 Dec; 28(12):2181-3. PubMed ID: 22965773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical transmission of the neurofibromatosis/Noonan syndrome.
    Quattrin T; McPherson E; Putnam T
    Am J Med Genet; 1987 Mar; 26(3):645-9. PubMed ID: 3105315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.
    Rodenhiser DI; Ainsworth PJ; Coulter-Mackie MB; Singh SM; Jung JH
    J Med Genet; 1993 May; 30(5):363-8. PubMed ID: 8320697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis with fully expressed Noonan syndrome.
    Abuelo DN; Meryash DL
    Am J Med Genet; 1988 Apr; 29(4):937-41. PubMed ID: 3135755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of neurofibromatosis type 1 using RFLPs tightly linked to gene.
    Vivarelli R; Bartalani G; Berardi A; Calistri L; Balestri P; Fois A
    Childs Nerv Syst; 1993 Jun; 9(3):147-9. PubMed ID: 8104099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.